Condition (MeSH)
Endocarditis, Subacute Bacterial
ClinicalTrials.gov lists 10 trials for Endocarditis, Subacute Bacterial or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
10 of the 10 trials are tagged with Endocarditis, Subacute Bacterial itself; the rest are tagged with a narrower condition beneath it.
When did Endocarditis, Subacute Bacterial trials start? (8)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 4
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2023 | 1 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 1 |
| 2019 | 2 |
| 2018 | 2 |
| 2017 | 1 |
| 2013 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 10 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Endocarditis, Subacute Bacterial trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 3 |
| Phase 4 | 1 |
| Not applicable | 3 |
| Observational | 3 |
How many Endocarditis, Subacute Bacterial trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Active, not recruiting | 1 |
| Completed | 5 |
| Unknown status | 4 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Endocarditis, Subacute Bacterial? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| CEFTRIAXONE | 1 |
Interventions as named in the registry (5)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Hyperbaric Oxygen | 1 |
| Buprenorphine and Outpatient Parenteral Antibiotic Therapy | 1 |
| Ceftriaxone 4g/ 24h | 1 |
| 99mTc-Leukoscan® scintigraphy | 1 |
| Buprenorphine and standard of care antibiotic treatment | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Endocarditis, Subacute Bacterial trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Nonfatal overdose | 6 | 1 |
| Bacteremia | 5 | 1 |
| Vertebral osteomyelitis | 5 | 1 |
| Orthopedic surgery | 4 | 1 |
| Valve replacement | 4 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Endocarditis, Subacute Bacterial? (2)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Subacute bacterial endocarditis following ear acupuncture. | International journal of cardiology | 1985 | Yes |
| Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. | Circulation | 1972 | No |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.